Serum Institute of India Pvt. Ltd.

Quick facts

Marketed products

• DTP-HB-Hib vaccine · Immunology
  This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b pathogens.

Phase 3 pipeline

• BRV-PV Lot A + DPT-HepB-Hib + OPV · Immunology / Infectious Disease Prevention
  This is a combination vaccine that provides immunization against rotavirus, diphtheria, pertussis, tetanus, hepatitis B, Haemophilus influenzae type b, and poliomyelitis through simultaneous administration of inactivated and live attenuated viral/bacterial antigens.
• BRV-PV Lot B + DPT-HepB-Hib + OPV · Immunology / Infectious Disease Prevention
  This is a combination vaccine that provides immunization against rotavirus (BRV-PV), diphtheria, pertussis, tetanus, hepatitis B, Haemophilus influenzae type b, and poliomyelitis through inactivated and live attenuated viral/bacterial antigens.
• BRV-PV Lot C + DPT-HepB-Hib + OPV · Immunology / Infectious Disease Prevention
  This is a combination vaccine that provides immunization against rotavirus (BRV-PV), diphtheria, pertussis, tetanus, hepatitis B, Haemophilus influenzae type b, and poliomyelitis through active immune stimulation.
• Cervavac as three dose regimen · Oncology
  Cervavac is a therapeutic HPV vaccine that stimulates the immune system to target and eliminate cervical cancer cells expressing human papillomavirus antigens.
• Cervavac as two dose regimen · Oncology / Immunology
  Cervavac is a two-dose recombinant protein subunit vaccine that stimulates immune responses against human papillomavirus (HPV) types 16 and 18 to prevent cervical cancer and related precancerous lesions.
• Gardasil as three dose regimen · Oncology / Infectious Disease / Immunology
  Gardasil is a recombinant quadrivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 6, 11, 16, and 18.
• ROTARIX + DPT-HepB-Hib + OPV · Immunology / Infectious Disease Prevention
  This combination vaccine provides immunization against rotavirus, diphtheria, pertussis, tetanus, hepatitis B, Haemophilus influenzae type b, and poliomyelitis through inactivated and live attenuated viral/bacterial antigens.
• Sii Licensed IPV · Infectious Diseases
  IPV vaccine works by stimulating the body's immune system to produce antibodies against the poliovirus.
• SII Yellow Fever Vaccine · Immunology / Infectious Disease
  This live attenuated yellow fever vaccine stimulates the immune system to produce antibodies and cellular immunity against yellow fever virus.
• SII-YFV · Infectious Diseases
  SII-YFV is a vaccine that stimulates an immune response against the yellow fever virus.

Phase 1 pipeline

• Dengusiil · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Serum Institute of India Pvt. Ltd. portfolio CI brief
• Serum Institute of India Pvt. Ltd. pipeline updates RSS

Frequently asked questions about Serum Institute of India Pvt. Ltd.

Related

• DTP-HB-Hib vaccine · Immunology
• Sector hub: All tracked pharma companies